Requesting feedback on draft Community Group Report about a minimum representation of potential drug-drug interaction knowledge and evidence

Hello,

Would anyone interested please take a look at our draft Semantic Web in 
Health Care and Life Sciences Community Group Report?  It is  titled 
"Minimum Representation of Potential Drug-Drug Interaction Knowledge and 
Evidence - Technical and User-centered Foundation Specification." The 
abstract of this Report is copied below. The Report  is the culmination 
of more than 2 years of effort by a volunteer multidisciplinary task 
force. We feel that this is very close to being ready to publish.

The full draft of the note is located here:

http://localhost/~rdb20/hcls-drug-drug-interaction/


Feel free to email feedback to this list or post issues on the project's 
github: https://github.com/w3c/hcls-drug-drug-interaction/


Abstract:

The purpose of this Community Group Note is to provide a technical and 
user-centered foundation for a minimum information model for information 
about potential drug-drug interactions. The Note provides non-ambigous 
definitions for 10 core information items. It also provides 8 detailed 
best practice recommendations related to the 10 core information items. 
The definitions and recommendations are shown as both narrative and 
prototype JSON artifacts using 2 exemplar potential drug-drug 
interactions. Adoption of the recommendations by developers of PDDI 
knowledge artifacts will improve the usefulness of the artifacts within 
clinical workflows. Intended downstream applications include clinical 
decision support, drug product label enhancement, cohort identification, 
and other activities relevant to protecting patients from harm from drug 
interactions.


-- 
Richard D Boyce, PhD
Associate Professor of Biomedical Informatics and Clinical and Translational Science in the Clinical and Translational
Science Institute
Director of the Informatics Core for the Center of Excellence for Natural Product- Drug Interaction Research (NaPDI)
Faculty, Center for Pharmaceutical Policy and Prescribing
Faculty, Geriatric Pharmaceutical Outcomes and Gero-Informatics Research and Training Program
University of Pittsburgh
rdb20@pitt.edu
Office: 412-648-9219
Twitter: @bhaapgh

Received on Saturday, 23 February 2019 18:52:13 UTC